LEUKEMIA, MYELOID, ACUTE
Clinical trials for LEUKEMIA, MYELOID, ACUTE explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, MYELOID, ACUTE trials appear
Sign up with your email to follow new studies for LEUKEMIA, MYELOID, ACUTE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for leukemia that returns after transplant
Disease control CompletedThis small, early-stage study tested the safety of an experimental drug called flotetuzumab. It was given to a few adults with a type of blood cancer (AML) that had come back after they received a bone marrow transplant. The main goal was to see if the drug was safe and to find t…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug combo tested in battle against aggressive blood cancer
Disease control CompletedThis study tested the safety and effectiveness of combining two drugs, azacitidine and venetoclax, for adults aged 45-65 newly diagnosed with a fast-growing blood cancer called acute myeloid leukemia (AML). All 40 participants received the drug combination to try to put the cance…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: NA • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New combo drug trial aims to tame aggressive blood cancers
Disease control CompletedThis large, completed study tested if adding a new drug called pevonedistat to the standard treatment (azacitidine) could better control certain aggressive blood cancers. It involved 454 adults with high-risk myelodysplastic syndromes, chronic myelomonocytic leukemia, or low-blas…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New hope for Tough-to-Treat leukemia: testing a promising drug duo
Disease control CompletedThis study tested a new drug combination for adults with acute myeloid leukemia (AML), a type of blood cancer. The main goal was to find the safest and most effective dose of a new drug called liposomal annamycin when given with a standard chemotherapy drug, cytarabine. Researche…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: PHASE1, PHASE2 • Sponsor: Moleculin Biotech, Inc. • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC